Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Discontinuation Study Of Citalopram in Depressed Adolescents
NCT00249886Phase 3Withdrawn
- Sponsor
- Sunnybrook Health Sciences Centre
- Start
- Sep 2002
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of citalopram in major depressive disorder (MDD), sponsored by Sunnybrook Health Sciences Centre. Planned start Sep 2002; status: withdrawn.
02
Drugs
citalopram
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT00249886.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00249886.